Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 30, 2025 10:10 ET | Source: Precedence Research

CAR T-Cell Therapy Market Size to Surpass USD 146.55 Billion by 2034 Fueled by Innovations in Cancer Treatment and Growing Demand for Personalized Therapies

Ottawa, Oct. 30, 2025 (GLOBE NEWSWIRE) -- According to Statifacts, the global car t-cell therapy market size reached USD 5.51 billion in 2024 and is estimated to attain USD 146.55 billion by 2034,...
October 08, 2025 13:00 ET | Source: DelveInsight Business Research LLP

CAR T-Cell Therapy for Multiple Myeloma Market to Witness Upsurge in Growth by 2034 Owing to the Launch of Emerging Therapies | DelveInsight

New York, USA, Oct. 08, 2025 (GLOBE NEWSWIRE) -- CAR T-Cell Therapy for Multiple Myeloma Market to Witness Upsurge in Growth by 2034 Owing to the Launch of Emerging Therapies | DelveInsight The...
August 26, 2025 07:30 ET | Source: MarketsandMarkets Research Pvt. Ltd.

Global CAR T-Cell Therapy Market Set to Reach USD 29 Billion by 2029 | MarketsandMarkets™

Delray Beach, FL, Aug. 26, 2025 (GLOBE NEWSWIRE) -- The global CAR T-cell Therapy market, valued at US$3.7 billion in 2023, stood at US$5.5 billion in 2024 and is projected to advance at a resilient...
July 10, 2025 13:59 ET | Source: BCC Research LLC

CAR T-Cell Therapy Market to Surge at 40.2% CAGR Over the Next Five Years

Boston, July 10, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Current R&D Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy Market” is expected to grow...
May 26, 2025 14:36 ET | Source: Liv Hospital

Liv Hospital and Istinye University Announce Groundbreaking Academic Collaboration with University of Pennsylvania’s Perelman School of Medicine

Liv Hospital & Istinye Univ forge groundbreaking alliance with UPenn’s Perelman School to advance CAR T/proton therapy access and medical research in TR.
March 05, 2025 13:00 ET | Source: DelveInsight Business Research LLP

CAR T-cell Therapy Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain

New York, USA, March 05, 2025 (GLOBE NEWSWIRE) -- CAR T-cell Therapy Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the...
November 20, 2024 07:30 ET | Source: FACT.MR

Metastatic Colorectal Cancer Market Forecast to Reach US$ 9,787.5 Million by 2034, Growing at 5.1% CAGR | Fact.MR Report

Rockville, MD, Nov. 20, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global metastatic colorectal cancer market is estimated to reach a...
July 01, 2024 11:00 ET | Source: Precedence Research

CAR T-Cell Therapy Market Size Expected to Reach USD 107.92 Billion by 2033

Ottawa, July 01, 2024 (GLOBE NEWSWIRE) -- The global CAR T-cell therapy market size is predicted to increase from USD 8.44 billion in 2023 to approximately USD 107.92 billion by 2033, According to...
October 17, 2023 09:05 ET | Source: CARGO Therapeutics, Inc.

CARGO Therapeutics Announces Appointment of Ginna Laport, MD, as Chief Medical Officer

— Accomplished clinical leader with significant expertise in hematology/oncology drug development and a track record of advancing multiple modalities of cancer therapeutics — SAN MATEO, Calif., Oct. ...
September 12, 2023 09:05 ET | Source: CARGO Therapeutics, Inc.

CARGO Therapeutics Announces Appointment of Michael Ports, PhD, as Chief Scientific Officer

– Scientific leader with multi-company cell therapy drug development experience spanning early discovery initiatives through late-stage development – SAN MATEO, Calif., Sept. 12, 2023 (GLOBE...